ATNF
Price
$1.56
Change
-$0.02 (-1.27%)
Updated
Jan 17 closing price
Capitalization
4.96M
SYGGF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 14 closing price
Capitalization
6.87M
Ad is loading...

ATNF vs SYGGF

Header iconATNF vs SYGGF Comparison
Open Charts ATNF vs SYGGFBanner chart's image
180 Life Sciences
Price$1.56
Change-$0.02 (-1.27%)
Volume$90.1K
Capitalization4.96M
Synairgen
Price$0.03
Change-$0.00 (-0.00%)
Volume$396
Capitalization6.87M
ATNF vs SYGGF Comparison Chart
Loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYGGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNF vs. SYGGF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNF is a Hold and SYGGF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ATNF: $1.56 vs. SYGGF: $0.03)
Brand notoriety: ATNF and SYGGF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNF: 16% vs. SYGGF: 5%
Market capitalization -- ATNF: $4.96M vs. SYGGF: $6.87M
ATNF [@Biotechnology] is valued at $4.96M. SYGGF’s [@Biotechnology] market capitalization is $6.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNF’s FA Score shows that 0 FA rating(s) are green whileSYGGF’s FA Score has 1 green FA rating(s).

  • ATNF’s FA Score: 0 green, 5 red.
  • SYGGF’s FA Score: 1 green, 4 red.
According to our system of comparison, SYGGF is a better buy in the long-term than ATNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNF’s TA Score shows that 2 TA indicator(s) are bullish while SYGGF’s TA Score has 3 bullish TA indicator(s).

  • ATNF’s TA Score: 2 bullish, 6 bearish.
  • SYGGF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SYGGF is a better buy in the short-term than ATNF.

Price Growth

ATNF (@Biotechnology) experienced а +3.31% price change this week, while SYGGF (@Biotechnology) price change was -12.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ATNF is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYGGF($6.87M) has a higher market cap than ATNF($4.96M). SYGGF YTD gains are higher at: -10.877 vs. ATNF (-14.286).
ATNFSYGGFATNF / SYGGF
Capitalization4.96M6.87M72%
EBITDA-2.99MN/A-
Gain YTD-14.286-10.877131%
P/E Ratio0.20N/A-
Revenue0N/A-
Total Cash195KN/A-
Total Debt3.26MN/A-
FUNDAMENTALS RATINGS
ATNF: Fundamental Ratings
ATNF
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNFSYGGF
RSI
ODDS (%)
Bearish Trend 12 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
70%
Bullish Trend 12 days ago
84%
Momentum
ODDS (%)
Bearish Trend 12 days ago
84%
N/A
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
83%
Advances
ODDS (%)
Bullish Trend 27 days ago
86%
Bullish Trend 25 days ago
72%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 13 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
80%
Bullish Trend 12 days ago
78%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
86%
View a ticker or compare two or three
Ad is loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYGGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPURX25.420.20
+0.79%
Fidelity Puritan
FEQHX13.320.10
+0.76%
Fidelity Hedged Equity
LSWWX25.120.15
+0.60%
Loomis Sayles Global Allocation Y
TRASX15.340.06
+0.39%
T. Rowe Price Asia Opportunities I
DRRYX15.450.05
+0.32%
BNY Mellon Global Real Return - Y

ATNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNF has been loosely correlated with PRQR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNF jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNF
1D Price
Change %
ATNF100%
-1.27%
PRQR - ATNF
49%
Loosely correlated
+3.04%
JSPR - ATNF
41%
Loosely correlated
+3.18%
WVE - ATNF
39%
Loosely correlated
-2.83%
BDRX - ATNF
38%
Loosely correlated
-1.38%
KRRO - ATNF
37%
Loosely correlated
+0.05%
More

SYGGF and

Correlation & Price change

A.I.dvisor tells us that SYGGF and INAB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SYGGF and INAB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYGGF
1D Price
Change %
SYGGF100%
N/A
INAB - SYGGF
27%
Poorly correlated
-0.13%
ATNF - SYGGF
20%
Poorly correlated
-1.27%
AWKNF - SYGGF
15%
Poorly correlated
N/A
CNTX - SYGGF
3%
Poorly correlated
+3.23%
CING - SYGGF
2%
Poorly correlated
-4.42%
More